The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Role of antibiotics for treatment of inflammatory bowel disease
Open accessAbstract
Inflammatory bowel disease is thought to be caused by an aberrant immune response to gut bacteria in a genetically susceptible host. The gut microbiota plays an important role in the pathogenesis and complications of the two main inflammatory bowel diseases: Crohn's disease (CD) and ulcerative colitis. Alterations in gut microbiota, and specifically reduced intestinal microbial diversity, have been found to be associated with chronic gut inflammation in these disorders. Specific bacterial pathogens, such as virulent Escherichia coli strains, Bacteroides spp, and Mycobacterium avium subspecies paratuberculosis, have been linked to the pathogenesis of inflammatory bowel disease. Antibiotics may influence the course of these diseases by decreasing concentrations of bacteria in the gut lumen and altering the composition of intestinal microbiota. Different antibiotics, including ciprofloxacin, metronidazole, the combination of both, rifaximin, and anti-tuberculous regimens have been evaluated in clinical trials for the treatment of inflammatory bowel disease. For the treatment of active luminal CD, antibiotics may have a modest effect in decreasing disease activity and achieving remission, and are more effective in patients with disease involving the colon. Rifamixin, a non absorbable rifamycin has shown promising results. Treatment of suppurative complications of CD such as abscesses and fistulas, includes drainage and antibiotic therapy, most often ciprofloxacin, metronidazole, or a combination of both. Antibiotics might also play a role in maintenance of remission and prevention of post operative recurrence of CD. Data is more sparse for ulcerative colitis, and mostly consists of small trials evaluating ciprofloxacin, metronidazole and rifaximin. Most trials did not show a benefit for the treatment of active ulcerative colitis with antibiotics, though 2 meta-analyses concluded that antibiotic therapy is associated with a modest improvement in clinical symptoms. Antibiotics show a clinical benefit when used for the treatment of pouchitis. The downsides of antibiotic treatment, especially with recurrent or prolonged courses such as used in inflammatory bowel disease, are significant side effects that often cause intolerance to treatment, Clostridium dificile infection, and increasing antibiotic resistance. More studies are needed to define the exact role of antibiotics in inflammatory bowel diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A.-L., Barnich, N., Bringer, M.-A., Swidsinski, A., Beaugerie, L., & Colombel, J.-F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.061 · Cited by 1,566
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A., Ahmad, T., Arnott, I., Driscoll, R., Mitton, S., Orchard, T., Rutter, M., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,419
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., Balish, E., & Hammer, R. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2359 · Cited by 1,156
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
Schwartz, D. A., Loftus, E. V., Tremaine, W. J., Panaccione, R., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32362 · Cited by 1,144
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3380-3389.2005 · Cited by 894
D'Haens, G. R., Geboes, K., Peeters, M., Baert, F., Penninckx, F., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 868
Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743
Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis
Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569
Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland, L., Singleton, J., Sessions, J., Hanauer, S., Krawitt, E., Rankin, G., Summers, R., Mekhjian, H., Greenberger, N., & Kelly, M. (1991) · Gut · doi:10.1136/gut.32.9.1071 · Cited by 528
Feller, M., Huwiler, K., Stephan, R., Altpeter, E., Shang, A., Furrer, H., Pfyffer, G. E., Jemmi, T., Baumgartner, A., & Egger, M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70211-6 · Cited by 526
Olaison, G., Smedh, K., & Sjodahl, R. (1992) · Gut · doi:10.1136/gut.33.3.331 · Cited by 495
Antibiotic use and inflammatory bowel diseases in childhood
Hviid, A., Svanstrom, H., & Frisch, M. (2011) · Gut · doi:10.1136/gut.2010.219683 · Cited by 492
Boudeau, J., Glasser, A.-L., Masseret, E., Joly, B., & Darfeuille-Michaud, A. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4499-4509.1999 · Cited by 448
Role of the intestinal microbiome in health and disease: from correlation to causation
de Vos, W. M., & de Vos, E. A. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00505.x · Cited by 440
Healing of perineal Crohn's disease with metronidazole
Bernstein, L. H., Frank, M. S., Brandt, L. J., & Boley, S. J. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90155-9 · Cited by 440
Ungaro, R., Bernstein, C. N., Gearry, R., Hviid, A., Kolho, K.-L., Kronman, M. P., Shaw, S., Van Kruiningen, H., Colombel, J.-F., & Atreja, A. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.246 · Cited by 384
Selby, W., Pavli, P., Crotty, B., Florin, T., Radford-Smith, G., Gibson, P., Mitchell, B., Connell, W., Read, R., Merrett, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.031 · Cited by 362
Inflammatory Bowel Disease: An Expanding Global Health Problem
M'koma, A. E. (2013) · Clinical Medicine Insights: Gastroenterology · doi:10.4137/cgast.s12731 · Cited by 359
Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease
Bernell, O., Lapidus, A., & Hellers, G. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01589.x · Cited by 335
Prantera, C., Zannoni, F., Scribano, M. L., Berto, E., Andreoli, A., Kohn, A., & Luzi, C. (1996) · PubMed · Cited by 309
D'Haens, G. R., Vermeire, S., Van Assche, G., Noman, M., Aerden, I., Van Olmen, G., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.010 · Cited by 301
Chapman, R. W., Selby, W. S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.10.1210 · Cited by 284
Manipulating the gut microbiota to maintain health and treat disease
Scott, K. P., Antoine, J.-M., Midtvedt, T., & van Hemert, S. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.25877 · Cited by 281
Ståhlberg, D., Gullberg, K., Liljeqvist, L., Hellers, G., & Löfberg, R. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02054692 · Cited by 265
West, R. L., van der Woude, C. J., Hansen, B. E., Felt‐Bersma, R. J. F., van Tilburg, A. J. P., Drapers, J. A. G., & Kuipers, E. J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02247.x · Cited by 256
Singh, S., Stroud, A. M., Holubar, S. D., Sandborn, W. J., & Pardi, D. S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001176.pub3 · Cited by 251
TURUNEN, U., FARKKILA, M., HAKALA, K., SEPPALA, K., SIVONEN, A., OGREN, M., VUORISTO, M., VALTONEN, V, & MIETTINEN, T. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70076-9 · Cited by 229
The safety profile of the fluoroquinolones
Bertino, J., & Fish, D. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80053-3 · Cited by 218
Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
Steinhart, A. H., Feagan, B. G., Wong, C. J., Vandervoort, M., Mikolainis, S., Croitoru, K., Seidman, E., Leddin, D. J., Bitton, A., Drouin, E., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34225 · Cited by 216
Preliminary Study of Ciprofloxacin in Active Crohn's Disease
Arnold, G. L., Beaves, M. R., Pryjdun, V. O., & Mook, W. J. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200201000-00002 · Cited by 181
Role of commensal gut bacteria in inflammatory bowel diseases
Loh, G., & Blaut, M. (2012) · Gut Microbes · doi:10.4161/gmic.22156 · Cited by 177
Prantera, C., Lochs, H., Grimaldi, M., Danese, S., Scribano, M. L., & Gionchetti, P. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.032 · Cited by 176
Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease?: Table 1
Sartor, R. B. (2005) · Gut · doi:10.1136/gut.2004.055889 · Cited by 175
Nitzan, O. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7577 · Cited by 174
Self-citationMantzaris, G. J., Hatzis, A., Kontogiannis, P., & Triadaphyllou, G. (1994) · PubMed · Cited by 171
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
Stein, R. B., & Hanauer, S. B. (2000) · Drug Safety · doi:10.2165/00002018-200023050-00006 · Cited by 167
The efficacy of tobramycin in the treatment of ulcerative colitis
BURKE, D. A., AXON, A. T. R., CLAYDEN, S. A., DIXON, M. F., JOHNSTON, D., & LACEY, R. W. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00456.x · Cited by 166
Mantzaris, G. J., Petraki, K., Archavlis, E., Amberiadis, P., Kourtessas, D., Christidou, A., & Triantafyllou, G. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750305503 · Cited by 160
Gionchetti, P., Rizzello, F., Ferrieri, A., Venturi, A., Brignola, C., Ferretti, M., Peruzzo, S., Miglioli, M., & Campieri, M. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026648812439 · Cited by 150
Petersen, A. M., Mirsepasi‐Lauridsen, H. C., Halkjær, S. I., Mortensen, E. M., Nordgaard-Lassen, I., & Krogfelt, K. A. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.06.001 · Cited by 148
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis
Nishikawa, J., Kudo, T., Sakata, S., Benno, Y., & Sugiyama, T. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802433231 · Cited by 145
Wang, S., Wang, Z., & Yang, C. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.718 · Cited by 137
Holubar, S. D., Cima, R. R., Sandborn, W. J., & Pardi, D. S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001176.pub2 · Cited by 135
Clinical guidelines for the management of pouchitis
Pardi, D. S., D’Haens, G., Shen, B., Campbell, S. S., & Gionchetti, P. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21039 · Cited by 130
Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth
Lauritano, E. C., Gabrielli, M., Lupascu, A., Santoliquido, A., Nucera, G., Scarpellini, E., VINCENTI, F., Cammarota, G., Flore, R. A., POLA, P., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02516.x · Cited by 124
Healing of perineal Crohn's disease with metronidazole.
Bernstein, L. H., Frank, M. S., Brandt, L. J., et al. (1980) · PubMed · Cited by 111
Prideaux, L., Kang, S., Wagner, J., Buckley, M. J., Mahar, J. E., Cruz, P. P. D., Wen, Z., Chen, L., Xia, B., van Langenberg, D. R., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435759.05577.12 · Cited by 110
A meta-analysis of antimycobacterial therapy for Crohn's disease
Borgaonkar, M. R., MacIntosh, D. G., & Fardy, J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01842.x · Cited by 107
A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
Mantzaris, G. J., Archavlis, E., Christoforidis, P., Kourtessas, D., Amberiadis, P., Florakis, N., Petraki, K., Spiliadi, C., & Triantafyllou, G. (1997) · PubMed · Cited by 106
Historical Aspects of Inflammatory Bowel Disease
Kirsner, J. B. (1988) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198806000-00012 · Cited by 106
Rifaximin for maintenance therapy in antibiotic-dependent pouchitis
Shen, B., Remzi, F. H., López, R., & Queener, E. Y. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-26 · Cited by 90
Use of antibiotics in patients with C rohn's disease: A systematic review and meta‐analysis
Su, J. W., Jing, J., & Zhang, H. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12216 · Cited by 79
Oral tobramycin in ulcerative colitis: effect on maintenance of remission
Lobo, A., Burke, D., Sobala, G. M., & Axon, A. T. R. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00084.x · Cited by 76
Kothary, V., Scherl, E., Bosworth, B. P., Jiang, Z., DuPont, H. L., Harel, J., Simpson, K. W., & Dogan, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02163-12 · Cited by 57
Prevention of post-operative recurrence of Crohn’s disease
Vaughn, B. P., & Moss, A. C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1147 · Cited by 55
Rifaximin in the treatment of inflammatory bowel disease
Guslandi, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i42.4643 · Cited by 51
Midtvedt, T., Zabarovsky, E. R., Norin, E. L., Bark, J., Gizatullin, R. Z., Kashuba, V. I., Ljungqvist, O. H., Zabarovska, V. I., Möllby, R., & Ernberg, I. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066074 · Cited by 49
Management of Crohn's disease--a practical approach.
Knutson, D., Greenberg, G. R., & Cronau, H. (2003) · PubMed · Cited by 48
Neurologic Complications of Metronidazole
Sarna, J. R., Furtado, S., & Brownell, A. K. W. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015870 · Cited by 48
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management
Kerman, D. H., & Deshpande, A. R. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2779 · Cited by 47
McLaughlin, S. D., Clark, S. K., Shafi, S., Petrovska, L., Tekkis, P. P., Ciclitira, P. J., & Nicholls, R. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.01.002 · Cited by 47
Kato, K., Ohkusa, T., Terao, S., Chiba, T., Murakami, K., Yanaka, A., Uehara, T., Ishii, Y., Soma, M., & Tajiri, H. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12688 · Cited by 45
Tahan, S., Melli, L. C. F. L., Mello, C. S., Rodrigues, M. S. C., Filho, H. B. D. A., & de Morais, M. B. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3182952e93 · Cited by 44
Gilat, T., Leichtmann, G. A., Delpré, G., Eshchar, J., Meir, S. B., & Fireman, Z. (1989) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198908000-00008 · Cited by 41
Swidsinski, A. V., Loening-Baucke, V. A., Bengmark, S., Scholze, J. E., & Dörffel, Y. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.08.001 · Cited by 39
Ciprofloxacin-induced Q-T interval prolongation
Knorr, J. P., Moshfeghi, M., & Sokoloski, M. C. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070081 · Cited by 38
Sánchez-Montes, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13999 · Cited by 38
Is Rifaximin Effective in Maintaining Remission in Crohn's Disease?
Jigaranu, A. O., Nedelciuc, O., Blaj, A., Badea, M., Mihai, C., Diculescu, M., & Prelipcean, C. C. (2014) · Digestive Diseases · doi:10.1159/000358141 · Cited by 37
Biancone, L., Vernia, P., Agostini, D., Ferrieri, A., & Pallone, F. (2000) · Current Medical Research and Opinion · doi:10.1185/0300799009117003 · Cited by 36
Ciprofloxacin Usage and Bacterial Resistance Patterns in Crohn’s Disease Patients With Abscesses
Park, S., Kim, K.-J., Lee, S., Yang, D., Jung, K. W., Ye, B. D., Byeon, J., Myung, S., Yang, S., Kim, J.-H., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000024 · Cited by 22
Managing Clostridium difficile in Inflammatory Bowel Disease (IBD)
Hashash, J. G., & Binion, D. G. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0393-1 · Cited by 20
Zatorski, H., & Fichna, J. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00019 · Cited by 12
Cited by
Adherent-invasive Escherichia coli in inflammatory bowel disease
Palmela, C., Chevarin, C., Xu, Z., Torres, J., Sevrin, G., Hirten, R., Barnich, N., Ng, S. C., & Colombel, J.-F. (2018) · Gut · doi:10.1136/gutjnl-2017-314903 · Cited by 535
Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
Zhang, M., Sun, K., Wu, Y., Yang, Y., Tso, P., & Wu, Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00942 · Cited by 347
Ganji‐Arjenaki, M., & Rafieian‐Kopaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25911 · Cited by 314
The promise of the gut microbiome as part of individualized treatment strategies
Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00499-1 · Cited by 217
Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis
Schepper, J. D., Collins, F., Rios-Arce, N. D., Kang, H. J., Schaefer, L., Gardinier, J. D., Raghuvanshi, R., Quinn, R. A., Britton, R., Parameswaran, N., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3947 · Cited by 199
Metadata
- Authors
- Nitzan, O.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 3
- Pages
- 1078
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2254262042
- Cited by
- 279
- References
- 86
- FWCI
- 16.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.